Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

Online
ISSN
1437-4331
See all formats and pricing
Volume 51, Issue 6 (Jun 2013)

Issues

Opinion paper on innovative approach of biomarkers for infectious diseases and sepsis management in the emergency department

Salvatore Di Somma
  • Corresponding author
  • Department of Medical-Surgery Sciences and Translational Medicine, University ‘Sapienza’ Rome, Sant’Andrea Hospital, Rome, Italy
  • Emergency Medicine Department, Sant’ Andrea Hospital, Via di Grottarossa 1035-1039, Rome 00189, Italy
  • Email:
/ Laura Magrini
  • Emergency Medicine Department, Sant’Andrea Hospital, University of Rome ‘Sapienza’ School of Medicine and Psychology, Rome, Italy
/ Francesco Travaglino
  • Emergency Medicine Department, Sant’Andrea Hospital, University of Rome ‘Sapienza’ School of Medicine and Psychology, Rome, Italy
/ Irene Lalle
  • Emergency Medicine Department, Sant’Andrea Hospital, University of Rome ‘Sapienza’ School of Medicine and Psychology, Rome, Italy
/ Nicola Fiotti
  • Emergency Medicine Department, University of Trieste, Trieste, Italy
/ Grianfranco Cervellin
  • Emergency Department, University Hospital of Parma, Parma, Italy
/ Gian Carlo Avanzi
  • Department of Translational Medicine, Eastern Piedmont University, Novara, Italy
/ Enrico Lupia
  • Department of Medical Sciences, University of Turin, Torino, Italy
/ Alan Maisel
  • San Diego Veterans Affairs, University California, San Diego, CA, USA
/ Frauke Hein
  • Adrenomed AG, Hennigsdorf, Germany
/ Florian Wagner
  • Anesthesiology, University Medical School, Ulm, Germany
/ Giuseppe Lippi
  • Department of Medical-Surgery Sciences and Translational Medicine, University ‘Sapienza’ Rome, Sant’Andrea Hospital, Rome, Italy
  • Laboratory of Clinical Chemistry and Haematology, Academic Hospital of Parma, Parma, Italy
Published Online: 2013-02-07 | DOI: https://doi.org/10.1515/cclm-2012-0795

Abstract

Sepsis is a leading healthcare problem, accounting for the vast majority of fatal events in critically ill patients. Beyond early diagnosis and appropriate treatment, this condition requires a multifaceted approach for monitoring the severity, the potential organ failure as well as the risk of death. Monitoring of the efficacy of treatment is also a major issue in the emergency department (ED). The assessment of critically ill conditions and the prognosis of patients with sepsis is currently based on some scoring systems, which are, however, inefficient to provide definite clues about organ failure and prognosis in general. The discretionary and appropriate use of some selected biomarkers such as procalcitonin, inducible protein 10 (IP10), Group IV phospholipase A2 type II (PLA2 II), neutrophil gelatinase-associated lipocalin (NGAL), natriuretic peptides, mature adrenomedullin (ADM), mid-regional pro-adrenomedullin (MR-proADM), copeptin, thrombopoietin, Mer receptor and even red blood cell distribution width (RDW) represent thereby an appealing perspective in the diagnosis and management of patients with sepsis. Nevertheless, at the moment, it is not still clear if it is better to use a multimarkers approach or if a single, most appropriate, biomarker exists. This collective opinion paper is aimed at providing an overview about the potential clinical usefulness of some innovative biomarkers of sepsis in its diagnosis and prognosis, but also in the treatment management of the disease. This manuscript represents a synopsis of the lectures of Third Italian GREAT Network Congress, that was hold in Rome, 15–19 October 2012.

Keywords: biomarkers; emergency department; infection; procalcitonin; sepsis

References

  • 1.

    Gaieski DF, Mikkelsen ME, Band RA, Pines JM, Massone R, Furia FF, et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 2010;38:1045–53. [PubMed] [Web of Science] [Crossref]

  • 2.

    Adib-Conquy M, Cavaillon JM. Stress molecules in sepsis and systemic inflammatory response syndrome. FEBS Lett 581 2007;58:3723–33. [Web of Science]

  • 3.

    Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care 2010;14:R15. [Crossref]

  • 4.

    Neville LF, Mathiak G, Bagasra O. The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. Cytokine Growth F R 1997;8:207–19. [Crossref]

  • 5.

    Liu MS, Liu CH, Wu G, Zhou Y. Antisense inhibition of secretory and cytosolic phospholipase A2 reduces the mortality in rats with sepsis. Crit Care Med 2012;40:2132–40. [Crossref] [Web of Science]

  • 6.

    Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother 2011;66(Suppl 2):ii33–40. [Web of Science]

  • 7.

    Cervellin G, Pedrazzoni M, Passeri M. New polypeptide hormonal candidates encoded by the calcitonin gene. Rec Progr Med 1983;74:979–85.

  • 8.

    Hausfater P, Brochet C, Freund Y, Charles V, Bernard M. Procalcitonin measurement in routine emergency medicine practice: comparison between two immunoassays. Clin Chem Lab Med 2010;48:501–4. [Web of Science] [PubMed]

  • 9.

    Bele N, Darmon M, Coquet I, Feugeas JP, Legriel S, Adaoui N, et al. Diagnostic accuracy of procalcitonin in critically ill immunocompromised patients. Infect Dis 2011;11:224–32. [Web of Science]

  • 10.

    Maisel A, Neath SX, Landsberg J, Mueller C, Nowak RM, Peacock WF, et al. Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial. Eur J Heart Failure 2012;14:278–86. [Web of Science] [Crossref]

  • 11.

    Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections. The ProHOSP Randomized Controlled Trial. J Am Med Assoc 2009; 302:1059–66. [Crossref] [Web of Science]

  • 12.

    Lippi G, Meschi T, Cervellin G. Inflammatory biomarkers for the diagnosis, monitoring and follow-up of community-acquired pneumonia: clinical evidence and perspectives. Eur J Intern Med 2011;22:460–5. [Web of Science] [Crossref] [PubMed]

  • 13.

    Cervellin G, Di Somma S. Neutrophil gelatinase-associated lipocalin (NGAL): the clinician’s perspective. Clin Chem Lab Med 2012;50:1489–93. [Web of Science]

  • 14.

    Chelazzi C, Villa G, De Gaudio AR. Cardiorenal syndromes and sepsis. Int J Nephrol 2011;2011:652967. [PubMed]

  • 15.

    Charles PE, Kus E, Aho S, Prin S, Doise JM, Olsson NO, et al. Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report. BMC Infect Dis 2009;9:49–58. [PubMed] [Crossref] [Web of Science]

  • 16.

    Harbarth S, Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001; 164:396–402. [Crossref]

  • 17.

    Lippi G, Cervellin G. Estimation of glomerular filtration rate in acute kidney injury. Clin Chim Acta 2012;414C:34–5. [Web of Science]

  • 18.

    Lippi G, Plebani M. Neutrophil gelatinase-associated lipocalin (NGAL): the laboratory perspective. Clin Chem Lab Med 2012;50:1483–7. [Web of Science]

  • 19.

    Clerico A, Galli C, Fortunato A, Ronco C. Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences. Clin Chem Lab Med 2012;50:1505–17. [Web of Science]

  • 20.

    Lentini P, de Cal M, Clementi A, D’Angelo A, Ronco C. Sepsis and AKI in ICU patients: the role of plasma biomarkers. Crit Care Res Pract 2012;2012:856401. [PubMed]

  • 21.

    Shapiro NI, Trzeciak S, Hollander JE, Birkhahn R, Otero R, Osborn TM, et al. The diagnostic accuracy of plasma neutrophil gelatinase-associated lipocalin in the prediction of acute kidney injury in emergency department patients with suspected sepsis. Ann Emerg Med 2010;56:52–9. [Web of Science] [PubMed] [Crossref]

  • 22.

    Magrini L, Travaglino F, Marino R, Ferri E, De Berardinis B, Cardelli P, et al. Procalcitonin variations after emergency department admission are highly predictive of hospital mortality in patients with acute infectious diseases. Eur Rev Med Pharmacol Sci 2013 (in press).

  • 23.

    Lippi G, Cervellin G. Neutrophil gelatinase-associated lipocalin: a more specific assay is needed for diagnosing renal injury. Clin Chim Acta 2012;413:1160–1. [Web of Science]

  • 24.

    Lippi G, Cervellin G. The predictive value of plasma neutrophil gelatinase-associated lipocalin on cardiovascular death and all-cause mortality might be mediated by leukocytosis. J Am Coll Cardiol 2012;60:564–5. [Web of Science] [PubMed] [Crossref]

  • 25.

    Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296–327. [Crossref] [PubMed]

  • 26.

    Marshall JC, Reinhart K. Biomarkers of sepsis. Crit Care Med 2009;37:2290–8. [Crossref] [PubMed] [Web of Science]

  • 27.

    Travaglino F, De Berardinis B, Magrini L, Bongiovanni C, Candelli M, Silveri NG, et al. Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score. BMC Infect Dis 2012;12:184–92. [Web of Science] [Crossref]

  • 28.

    Kuter DJ. Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia. Annu Rev Med 2009;60:193–206. [PubMed] [Web of Science] [Crossref]

  • 29.

    Lupia E, Goffi A, Bosco O, Montrucchio G. Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseases. Mediat Inflamm 2012;2012:390892. [Web of Science]

  • 30.

    Zakynthinos SG, Papanikolaou S, Theodoridis T, Zakynthinos EG, Christopoulou-Kokkinou V, Katsaris G, et al. Sepsis severity is the major determinant of circulating thrombopoietin levels in septic patients. Crit Care Med 2004;32:1004–10. [PubMed] [Crossref]

  • 31.

    Lupia E, Bosco O, Mariano F, Dondi AE, Goffi A, Spatola T, et al. Elevated thrombopoietin in plasma of burned patients without and with sepsis enhances platelet activation. J Thromb Haemost 2009;7:1000–8. [Web of Science] [PubMed] [Crossref]

  • 32.

    Lupia E, Spatola T, Cuccurullo A, Bosco O, Mariano F, Pucci A, et al. Thrombopoietin modulates cardiac contractility in vitro and contributes to myocardial depressing activity of septic shock serum. Basic Res Cardiol 2010;105:609–20. [Crossref] [PubMed] [Web of Science]

  • 33.

    Rothlin CV, Lemke G. TAM receptor signaling and autoimmune disease. Curr Opin Immunol 2010;22:740–6. [Crossref] [PubMed]

  • 34.

    Lu Q, Lemke G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 2001;293:306–11.

  • 35.

    Scott RS, McMahon EJ, Pop SM, Reap EA, Caricchio R, Cohen PL, et al. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 2001;411:207–11.

  • 36.

    Alciato F, Sainaghi PP, Sola D, Castello L, Avanzi GC. TNF-alpha, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages. J Leukocyte Biol 2010;87:869–75. [Crossref] [Web of Science]

  • 37.

    Thorp E, Vaisar T, Subramanian M, Mautner L, Blobel C, Tabas I. Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase Cδ, and p38 mitogen-activated protein kinase (MAPK). J Biol Chem 2011;286:33335–44. [Web of Science]

  • 38.

    Borgel D, Clauser S, Bornstain C, Bièche I, Bissery A, Remones V, et al. Elevated growth-arrest-specific protein 6 plasma levels in patients with severe sepsis. Crit Care Med 2006;34:219–22. [Crossref]

  • 39.

    Müller B, Gencay MM, Gibot S, Stolz D, Hunziker L, Tamm M, et al. Circulating levels of soluble triggering receptor expressed on myeloid cells (sTREM)-1 in community-acquired pneumonia. Crit Care 2007;35:990–1. [Crossref] [Web of Science]

  • 40.

    Ekman C, Linder A, Akesson P, Dahlbäck B. Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes. Crit Care 2010;14:158–63. [Web of Science]

  • 41.

    Bełtowski J, Jamroz A. Adrenomedullin – what do we know 10years since its discovery? Pol J Pharmacol 2004;56:5–27.

  • 42.

    Meeran K, O’Shea D, Upton PD, Small CJ, Ghatei MA, Byfield PH. Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study. J Clin Endocrinol Metab 1997;82:95–100. [PubMed]

  • 43.

    Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, et al. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 2010;55:2062–76. [Crossref] [Web of Science] [PubMed]

  • 44.

    Hinson JP, Kapas S, Smith DM. Adrenomedullin, a multifunctional regulatory peptide. Endocrinol Rev 2000;21:138–67.

  • 45.

    Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Comm 1993;192:553–60. [Crossref]

  • 46.

    Wu R, Higuchi S, Dong W, Ji Y, Zhou M, Marini CP, et al. Reversing established sepsis in rats with human vasoactive hormone adrenomedullin and its binding protein. Mol Med 2009; 15:28–33. [PubMed] [Web of Science]

  • 47.

    Guignant C, Voirin N, Venet F, Poitevin F, Malcus C, Bohé J, et al. Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients. Intens Care Med 2009;35:1859–67. [Web of Science] [Crossref]

  • 48.

    Lippi G, Teti L, Dipalo M, Cervellin G. Relationship between red blood cell distribution width and prognostic biomarkers in patients admitted to the emergency department with acute infections. Eur J Intern Med 2012 Sep 24. [Epub ahead of print]. [Web of Science]

About the article

Corresponding author: Salvatore Di Somma, Emergency Medicine Department, Sant’Andrea Hospital, Via di Grottarossa 1035-1039, Rome 00189, Italy, Phone: +39 633775581, Fax: +39 0633775890


Received: 2012-11-21

Accepted: 2012-12-27

Published Online: 2013-02-07

Published in Print: 2013-06-01


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2012-0795. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Mariella Dipalo, Ruggero Buonocore, Cecilia Gnocchi, Alessandra Picanza, Rosalia Aloe, and Giuseppe Lippi
Clinical Chemistry and Laboratory Medicine (CCLM), 2015, Volume 53, Number 4
[2]
Ying Yu, Xia-Xi Li, Ling-Xiao Jiang, Meng Du, Zhan-Guo Liu, Zhong-Ran Cen, Hua Wang, Zhen-Hui Guo, and Ping Chang
Infectious Diseases, 2015, Page 1
[3]
Fabian Benz, Frank Tacke, Mark Luedde, Christian Trautwein, Tom Luedde, Alexander Koch, and Christoph Roderburg
Disease Markers, 2015, Volume 2015, Page 1
[4]
Rodolfo Monteiro Enz Hubert, Melina Veiga Rodrigues, Bruna Dolci Andreguetto, Thiago M. Santos, Maria de Fátima Pereira Gilberti, Vagner de Castro, Joyce M. Annichino-Bizzacchi, Desanka Dragosavac, Marco Antonio Carvalho-Filho, and Erich Vinicius De Paula
Scientific Reports, 2015, Volume 5, Page 8019
[5]
Gian Luca Salvagno, Fabian Sanchis-Gomar, Alessandra Picanza, and Giuseppe Lippi
Critical Reviews in Clinical Laboratory Sciences, 2015, Volume 52, Number 2, Page 86

Comments (0)

Please log in or register to comment.
Log in